Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

ScienceDaily
Jul 6, 2019, 12:34 pm1.3k ptsInterestingTop
Some of the adverse events related to the use of regorafenib often limits its use in clinical practice. A study suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardizing efficacy.

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Volkswagen Announces Plan To Shutter Four Factories 74

Trump Tanked RV Sales, But There’s An Opportunity For EV Owners 74

Aptera Proved Its Solar Generation, Now It Needs To Prove Its Efficiency 66

Hawaii is turning ocean plastic and fishing nets into roads 53

Mountain lions changed everything in this tiny California preserve 50

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.